Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04487028 · ClinicalTrials.gov registry record
Dysphagia in Thoracic Surgical Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 61
- Enrollment target
NCT04487028: Completed study, sponsored by University of Florida.
NCT04487028 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04487028 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The proposed study seeks to determine the incidence of dysphagia and vocal fold mobility impairment (VFMI) in individuals undergoing throacic surgical procedures. It also seeks to determine the impact of postoperative swallowing impairment on health-related outcomes.
Primary Outcome
This scale is a validated measure used by trained blinded clinicians to assign ratings of safety to swallowing bolus trials. The development and use of an 8-point, equal-appearing interval scale (8 being best; 1 being worst) to describe penetration and aspiration events are described. Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled.
Interventions
- PROCEDURE Fiberoptic Endoscopic Evaluation of Swallowing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2021-11-22 |
What the finished NCT04487028 record still lists
NCT04487028 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fiberoptic Endoscopic Evaluation of Swallowing is the first listed.
NCT04487028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04487028 about?
NCT04487028 is a clinical study titled "Dysphagia in Thoracic Surgical Patients". The proposed study seeks to determine the incidence of dysphagia and vocal fold mobility impairment (VFMI) in individuals undergoing throacic surgical procedures. It also seeks to determine the impact of postoperative swallowing impairment on health-related outcomes.
What is the current status of trial NCT04487028?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2020-08-25. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT04487028?
The interventions under investigation include: Fiberoptic Endoscopic Evaluation of Swallowing (PROCEDURE).
Who is sponsoring clinical trial NCT04487028?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI